Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,409 | -50,317 | -174,523 | -124,137 | -72,950 |
| Depreciation Amortization | 533 | 260 | 492 | 283 | 117 |
| Accounts payable and accrued liabilities | 6,212 | 2,544 | 14,494 | 16,000 | 2,382 |
| Other Working Capital | -2,169 | 2,036 | 28,667 | 26,641 | 14,145 |
| Other Operating Activity | 5,541 | 4,538 | 13,828 | 4,429 | 11,455 |
| Operating Cash Flow | $-74,292 | $-40,939 | $-117,042 | $-76,784 | $-44,851 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,290 | -8,427 | -15,304 | -7,034 | -3,532 |
| Purchase Sale Intangibles | -3,250 | -3,000 | -6,250 | -6,000 | -5,500 |
| Other Investing Activity | -3,250 | -3,000 | -6,250 | -6,000 | -5,500 |
| Investing Cash Flow | $-19,540 | $-11,427 | $-21,554 | $-13,034 | $-9,032 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 39,957 | 29,978 | N/A |
| Common Stock Issued | 11,961 | 277 | N/A | N/A | N/A |
| Other Financing Activity | -993 | -384 | -874 | 0 | 0 |
| Financing Cash Flow | $10,968 | $-107 | $39,083 | $29,978 | $0 |
| Beginning Cash Position | 151,740 | 151,740 | 251,253 | 251,253 | 251,253 |
| End Cash Position | 68,876 | 99,267 | 151,740 | 191,413 | 197,370 |
| Net Cash Flow | $-82,864 | $-52,473 | $-99,513 | $-59,840 | $-53,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,292 | -40,939 | -117,042 | -76,784 | -44,851 |
| Capital Expenditure | -16,290 | -8,427 | -15,304 | -7,034 | -3,532 |
| Free Cash Flow | -90,582 | -49,366 | -132,346 | -83,818 | -48,383 |